Oxford Nanopore Technologies Ltd., an Oxford, UK-based developer of nanopore technology for the direct, electronic analysis of single molecules, has raised £25m (approximately $41m) in new funding.
Backers include Lansdowne Partners, IP Group, Invesco Perpetual, Redmile Group, Illumina and other undisclosed investors.
The company intends to use the funds to further develop and validate its proprietary technology for molecular analysis applications that include DNA sequencing and protein analysis. In addition to the development of techniques using biological nanopores, Oxford Nanopore has also strengthened existing projects and collaborations in the development of solid-state nanopores.
Formed in 2005 and led by CEO Dr Gordon Sanghera, the company has developed a platform technology, called GridION, that consists of a scalable modular instrument and self-contained consumable cartridge. GridION is adaptable for the analysis of different types of molecules including DNA and proteins by changing the types of nanopore included in the cartridge.